Meet BrosMed at ML CTO Endovascular Course 2024
Release time:
2024-04-23
BrosMed Medical is delighted to attend the upcoming 3rd edition MULTI-LEVEL CTO Endovascular Course from May 2nd to 3rd this year in beautiful Brussels, Belgium.
BrosMed Medical is delighted to attend the upcoming 3rd edition MULTI-LEVEL CTO Endovascular Course from May 2nd to 3rd this year in beautiful Brussels, Belgium.
Be sure to visit our booth to learn more about our product offerings and gain new insights into BrosMed launched Complex PAD & AVF Solutions:
Tri-Wedge™ PTA Scoring Balloon Dilatation Catheter: Three Triangular metallic wires 360° for precise & effective dilatation
Tiche™ High Pressure PTA Balloon Dilatation Catheter: Deliverable high pressure with a low tip entry profile 0.040”
We sincerely looking forward to meet you there and get inspiration from each other!
ABOUT BROSMED MEDICAL
Founded in 2012, BrosMed is a leading medical device multinational company specializing in R&D, production and global sales of high-performance intravascular interventional medical devices. We have operated four R&D centers(Labs), 2 manufacturing centers around China, Europe and Asian Pacific. BrosMed has more than 20 product series and 400+ products registration certificates in worldwide.
ABOUT Multi-Level CTO Endovascular Course
Multi-Level CTO Endovascular Course is conceived to bring together a multidisciplinary group of vascular specialists from Europe and Middle East to engage in the highest standard educational format with a spirit of collegiality and inclusion.
Join Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announces Canadian Approval of RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical today announced Canadian regulatory approval of the RevoEdge™ High-Pressure Cutting Balloon Dilatation Catheter, expanding the company’s presence in North America and marking another milestone in the global commercialization of its specialty coronary portfolio.
2026-09-14
BrosMed Announced CE MDR Approval of VascuGlide™ Microcatheter System
June 15, 2026-BrosMed is pleased to announce that the VascuGlide™ Microcatheter System has received CE MDR certification, marking another significant milestone in the company's commitment to advancing peripheral intervention solutions.
2026-06-18
